InvestorsHub Logo
Followers 118
Posts 1968
Boards Moderated 0
Alias Born 11/22/2017

Re: hyperopia post# 367234

Monday, 04/05/2021 6:02:39 AM

Monday, April 05, 2021 6:02:39 AM

Post# of 730941

So the first milestone (which was achieved) included the technology transfer of all relevant manufacturing protocols, and a document listing all technical and regulatory specifications for the EDEN system required to manufacture DCVax-L, finding a new supplier (Saint Gobain?) to make the single-use consumables, and then producing a prototype for Advent to test within 90 days of the agreement. (which was Nov 26th)



Thanks hyperopia and Harry for the additional information.
IMO their supplier is the French company Saint-Gobain, a worldwide leader in all of its businesses and represented in 70 countries.

Saint-Gobain supplies materials for the most critical medical applications. The keywords for this segment are reliability, safety and compliance with the most exacting standards. The Group also designs and develops products for habitat that help improve air quality and so inhabitants’ health.

HIGH-PERFORMANCE PLASTICS SERVING HEALTH

Hospitals, the pharmaceuticals industry and research laboratories: Saint-Gobain products are found throughout the medical sector.

Saint-Gobain develops high-performance plastics specifically for the health market. The Group, with its Life Sciences Business Unit is one of the world’s leading suppliers of polymer components for pharmaceutical, medical and biotechnology markets.

The materials developed, with unique barrier and biocompatibility properties, and allowing for the transmission of oxygen, are also used in scientific laboratories and for the large-scale production of vaccines. These single-use solutions have high growth potential, as they are increasingly used to replace systems made from stainless steel.

Saint-Gobain is counting on breakthrough innovations for both materials and processes. From the outset, the Group also implements a co-development approach with pharmaceutical majors and medical customers, as each new medication implies a new process using new components.


https://www.saint-gobain.com/en/solutions/health-and-biomedical
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News